Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTLI.L Regulatory News (TLI)

  • There is currently no data for TLI

Interim Management Statement

19 Nov 2013 16:15

RNS Number : 4452T
Alternative Asset Opps PCC Ltd
19 November 2013
 



 

 

19 November 2013

Alternative Asset Opportunities PCC Limited

(the "Company")

Interim Management Statement

 

This interim management statement relates to the period from 1 July 2013 to the date of publication of this statement and has been prepared solely to provide additional information in order to meet the relevant requirement of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

The Company is a closed-ended Guernsey registered protected cell company with one cell known as the US Traded Life Interests Fund (the "Fund").

 

Investment objective

The Company's investment objective in respect of the Fund is to provide investors with an attractive capital return through investment predominantly in a diversified portfolio of US Traded Life Interests ("TLIs").

 

Financial position and performance

The original published net asset value per share as at 30 June 2013 was 55.6 pence, but the Annual Report and Accounts adjusted this figure to 48.5 pence, a reduction of 12.8%, and explained the reasons for this change. Over the period to 31 October 2013, the Company's net asset value per share decreased by 1.9% from the adjusted figure to 47.6 pence. As at 31 October 2013, the shares were trading at a 13.9% discount to the net asset value. 

 

Five policy maturities on five lives were identified during the period. The gain from one policy maturity was recognised in the 31 July 2013 NAV adding circa 2.1 pence to the NAV per share. The gains from the other four policy maturities were recognised in the 31 October 2013 NAV, adding a total of 1.5 pence to the NAV per share. There have been, in aggregate, 50 policy maturities since the Fund's inception.

 

The Company's loan agreement with Allied Irish Banks plc is due to expire on 31 March 2014. The Company is currently in the process of negotiating a renewal of the loan agreement beyond that date. As at 18 November 2013, following repayment of the above maturity proceeds, there are no borrowings under the agreement and the cash balance stands at $1,708,096.

 

 

Material events and transactions in the period and since 31 October 2013

 

At the Annual General Meeting held on 13 November 2013 an ordinary resolution was passed to approve the continuance of the US Traded Life Interests Fund of the Company until the Annual General Meeting to be held in 2014.

The Board is not aware of any other material events during the period from 1 July 2013 to 31 October 2013, or in the period from 1 November 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

The tables below aim to give investors an appreciation of the effects of differing assumptions to both LE and IRR.

- The first line of NAVs in the table uses the 'Latest LE' assumption, that is to say either an LE based on a recently updated assessment (obtained on or after 1 April 2013), or for the remaining policies an adjusted LE based on the most recent LE obtained, increased by 12%. The average LE is shown for reference (4.9 years). NAV is then shown at four different discount rates, ranging from 10% to 20%. This shows the effect of IRR on current value, and it allows investors to assess the effects of policy sales if, for example, the portfolio was to be liquidated.

 

- The second line shows the effect of a further increase of one year in the valuation LEs.

 

- The third line shows the effect of a decrease of one year in the valuation LEs.

 

 

- Finally, the fourth line shows the outcome of assuming LEs are simply based on the current table of life expectancies for the general population, the 2008 Valuation Basic Table, i.e. ignoring LE assessments.

 

Sensitivity Matrix

Net Asset Value in pence per share on various assumptions as at 31 October 2013

 

Mortality Assumptions

Average LE

Discount Rates applied to cash flows

10%

Current (12%)

16%

20%

Latest LE

4.9

50.7

47.6

42.4

38.3

+1 year for all LEs

5.9

37.7

34.9

30.5

27.1

- 1 year for all LEs

3.9

65.1

61.8

56.2

51.6

Using 2008 VBT

5.0

50.4

47.2

41.8

37.6

 

 

Source: SL Investment Management Limited

 

Distribution of Life Expectancy estimates

 

The following table shows the distribution by LE band of the death benefit and number of lives in the portfolio. Lives are grouped by 6 month LE bands and the table shows the number of lives and the total death benefit in each group. The LEs are the valuation LEs used for the 31 October 2013 valuation.

 

It is important to note that the LE is an average of the estimated length of future lifetime for an individual with a given age and health status. The table is not, therefore, a prediction of when actual maturities will occur and is thus not a cashflow forecast.

 

 

LE Band (Years)

Number of Lives

Death Benefit

0 ≤ LE < 0.5

0

$ -

0.5 ≤ LE < 1

0

$ -

1 ≤ LE < 1.5

0

$ -

1.5 ≤ LE < 2

1

$ 1,300,000

2 ≤ LE < 2.5

2

$ 5,500,000

2.5 ≤ LE < 3

1

$ 2,000,000

3 ≤ LE < 3.5

5

$ 11,450,000

3.5 ≤ LE < 4

10

$ 14,036,918

4 ≤ LE < 4.5

16

$ 26,109,334

4.5 ≤ LE < 5

8

$ 13,075,240

5 ≤ LE < 5.5

14

$ 30,650,000

5.5 ≤ LE < 6

8

$ 9,714,265

6 ≤ LE < 6.5

6

$ 8,861,438

6.5 ≤ LE < 7

7

$ 12,401,195

7 ≤ LE < 7.5

3

$ 11,000,000

7.5 ≤ LE < 8

2

$ 2,500,000

LE ≥ 8

2

$ 3,000,000

Total

85

 $ 151,598,390

 

 

 

Top ten holdings

By reference to the most recent portfolio valuation of the Company as at 31 October 2013, the largest ten investments held by the Company, measured by life office exposure, were as follows:

 

 

 

 

Issuer

Number of policies

% of totalassets as at31 October 2013

American General Life Insurance Company (TX)

10

20.35%

Lincoln National Life Insurance Co

14

18. 32%

Transamerica Life Insurance Company

18

16.21%

Massachusetts Mutual Life Insurance Co

5

7.55%

MetLife Insurance Company of Connecticut

6

5.02%

Security Life of Denver Insurance Co

1

4.84%

John Hancock Life Insurance Company

6

4.48%

New York Life Insurance and Annuity Corp

5

4.08%

Aviva Life and Annuity Company of NY

4

3.95%

Genworth Life Insurance Company

1

2.47%

 

Company Information

 

Launch date 25 March 2004

EPIC TLI

Year end 30 June

Report & Accounts 2013 Annual Report posted October, Half-yearly posted February

AGM November

Price Information Financial Times (under INVESTMENT COMPANIES, listed as 'AltAstsOpps.')

 

Investor Information

 

The latest available portfolio information included in the interim and annual report and accounts can be accessed via www.allianzgi.co.uk/TLI (under the Professional Investors section).

 

By order of the Board

Alternative Asset Opportunities PCC Limited

 

Enquiries:

Peter Ingram

Company Secretary Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGWGGUPWGQB
Date   Source Headline
8th Dec 201612:38 pmRNSShareholder Update
5th Dec 201612:09 pmRNSListing Rule 15.6.8
29th Nov 201611:11 amRNSShareholder Update
22nd Nov 20162:35 pmRNSShareholder Update
17th Nov 201610:23 amRNSNet Asset Value and Shareholder Update
8th Nov 20163:13 pmRNSProposals for Voluntary Liquidation and EGM
2nd Nov 20164:33 pmRNSListing Rule 15.6.8
2nd Nov 201611:12 amRNSShareholder Update
2nd Nov 20169:42 amRNSHolding(s) in Company
26th Oct 201610:30 amRNSShareholder Update
25th Oct 20163:29 pmRNSHolding(s) in Company
20th Oct 20161:52 pmRNSNet Asset Value(s)
14th Oct 20163:39 pmRNSFinal Results
13th Oct 20161:54 pmRNSShareholder Update
10th Oct 20161:35 pmRNSResult of Meeting
4th Oct 20169:49 amRNSListing Rule 15.6.8
3rd Oct 20165:17 pmRNSPolicy Maturity
26th Sep 20161:33 pmRNSProposed disposal of portfolio - Update
16th Sep 20162:08 pmRNSNet Asset Value(s)
13th Sep 201612:49 pmRNSPublication and Submission of Circular to NSM
13th Sep 20167:00 amRNSChange of Investment Policy and Objective
6th Sep 201611:50 amRNSListing Rule 15.6.8
31st Aug 20167:00 amRNSDoc re. Policy Maturity
17th Aug 201610:16 amRNSNet Asset Value(s)
3rd Aug 20165:23 pmRNSListing Rule 15.6.8
15th Jul 20164:58 pmRNSNet Asset Value(s)
4th Jul 201611:49 amRNSListing Rule 15.6.8
23rd Jun 201612:37 pmRNSShareholder Update
16th Jun 20163:13 pmRNSNet Asset Value(s)
2nd Jun 20164:25 pmRNSListing Rule 15.6.8
26th May 20168:47 amRNSCost of Insurance
16th May 20165:07 pmRNSNet Asset Value(s)
11th May 20163:56 pmRNSPotential increase in the Cost of Insurance
4th May 201610:31 amRNSListing Rule 15.6.8
19th Apr 20168:46 amRNSNet Asset Value(s)
12th Apr 201612:40 pmRNSHolding(s) in Company
4th Apr 20163:31 pmRNSListing Rule 15.6.8
23rd Mar 20165:36 pmRNSHalf Yearly Report
15th Mar 201611:09 amRNSNet Asset Value(s)
8th Mar 20167:00 amRNSHalf Yearly Report
2nd Mar 201612:40 pmRNSListing Rule 15.6.8
1st Mar 201610:27 amRNSHolding(s) in Company
24th Feb 20164:16 pmRNSHome Member State - DTR 6.4.2
22nd Feb 20164:12 pmRNSPolicy Maturity
17th Feb 20167:00 amRNSNet Asset Value(s)
2nd Feb 20162:06 pmRNSListing Rule 15.6.8
18th Jan 20169:43 amRNSNet Asset Value(s)
5th Jan 20163:21 pmRNSListing Rule 15.6.8
4th Jan 20168:47 amRNSCompliance with Model Code
16th Dec 201512:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.